CHPA statement on FDA notice of part 15 public hearing on OTC Monograph System

24-02-2014 Business Wire HealthComments (0)


The Consumer Healthcare Products Association (CHPA) issued the following statement in response to the Food and Drug Administration’s (FDA) notice of a public hearing and request for comments on the Over-the-Counter (OTC) Drug Review (the Monograph system): “Each day, consumers rely on the more than 100,000 OTC products for convenient, real-time relief of symptoms associated with pain, colds, allergies, heartburn, skin conditions, and other ailments. CHPA members str

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top